{"id":"W2593330344","doi":"10.1007/978-3-319-33703-6_47","title":"Biosimilars in the Treatment of Inflammatory Bowel Disease","year":2017,"lang":"en","type":"book-chapter","venue":"","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biosimilar; Infliximab; Medicine; Innovator; Inflammatory bowel disease; Biologic Agents; Monoclonal antibody; Tumor necrosis factor alpha; Disease; Intensive care medicine; Immunology; Rheumatoid arthritis; Internal medicine; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002228796,0.0003089198,0.0004419863,0.0001088787,0.0000888215,0.00001263725,0.0004274849,0.0005547221,0.002006453],"category_scores_gemma":[0.00002869041,0.0001635176,0.0003384085,0.000006522178,0.0006347484,0.00002243723,0.00004161934,0.0002231922,0.0001100574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003991035,"about_ca_system_score_gemma":0.00008161947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001276622,"about_ca_topic_score_gemma":0.00007319437,"domain_scores_codex":[0.9989844,0.00008351443,0.0003667731,0.0003014656,0.00004519955,0.0002186474],"domain_scores_gemma":[0.9986601,0.0001903281,0.000219227,0.0008671673,0.00003494084,0.00002817425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002547396,0.002730542,0.01019523,0.0005769115,0.003880372,0.0008818976,0.001384408,0.000001592811,0.00518245,0.6597332,0.1236923,0.1891937],"study_design_scores_gemma":[0.0007264972,0.0003416495,0.004935873,0.0001070056,0.0002888694,0.000005565813,0.00001571715,0.000001024314,0.001124473,0.00837977,0.9838253,0.0002482586],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0005196399,0.01881434,0.00001109444,0.003420368,0.0006732675,0.0008311457,0.0003169025,0.00003186442,0.9753814],"genre_scores_gemma":[0.01066082,0.006708809,0.0001193377,0.0008347183,0.00007832208,0.0000239747,0.00007288939,0.00003288665,0.9814683],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.860133,"threshold_uncertainty_score":0.9989058,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03412152190006254,"score_gpt":0.2900760564330433,"score_spread":0.2559545345329808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}